Saturday - June 12, 2021
HHS: Biden Administration Announces U.S. Government Procurement of Merck's Investigational Antiviral Medicine for COVID-19 Treatment
June 10, 2021
WASHINGTON, June 10 -- The U.S. Department of Health and Human Services issued the following news release on June 9, 2021:

The Biden Administration announced that the U.S. government will procure approximately 1.7 million courses of an investigational antiviral treatment, molnupiravir (MK-4482), for COVID-19 from Merck, pending emergency use authorization (EUA) or approval from the U.S. Food and Drug Administration (FDA).

Molnupiravir (MK-4482) is designed to induce vir . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products